Study links sleep disorders to developing dementia 

A study published in npj dementia has linked sleep disorders with a doubling of the risk of developing a neurodegenerative disease such as dementia. 

Researchers from UK Dementia Research Institute at Cardiff University and the U.S. National Institutes of Health (NIH) Intramural Center for Alzheimer’s and Related Dementias, analysed data from electronic health records to examine the relationship between sleep and neurodegenerative disease.  

Professor Valentina Escott-Price, Study Co-Leader and Group Leader at the UK Dementia Research Institute at Cardiff University, says:  

“Through analysing over 1 million people’s health records, we have found evidence to suggest that having a sleep disorder significantly increases someone’s risk of going on to later develop a neurodegenerative disease. In fact, this increased risk was present for up to 15 years following a sleep disorder diagnosis, and the risk was even greater for people who experienced recurrent sleep disorders. 

Perhaps most interestingly, this increased risk was occurring independently of genetic risk factors for Alzheimer’s and Parkinson’s, with sleep disorders almost ‘compensating’ for low genetic risk. One would expect that if sleep disorders were caused by neurodegeneration, genetic risk of sleep disorder and neurodegenerative disease would line up. Further investigation is needed, but this points towards sleep disorders as a risk factor for these conditions.” 

You can read the study here: https://www.nature.com/articles/s44400-025-00008-0 

Similar Posts

  • QCS guidance updated

    Quality Compliance Systems (QCS), a company providing policies and toolkits to ensure care sector compliance with regulations, has refreshed and expanded its best practice guidance for supported living services. The content of existing policies has been updated with more inclusive language and new topics have been added such as positive behaviour support and communication. At…

  • Outstanding care recognised  

    Royal Star & Garter in Solihull has been recognised for its “outstanding person-centred dementia care”.  The Home received the Level 1 Accreditation from Meaningful Care Matters (MCM) following an audit which found the quality of life experienced by residents was at the highest level, with care provided by engaged and loving staff who care deeply…

  • Arts for Dementia running ‘Art Wednesdays’ 

    Arts for Dementia are running ‘Art Wednesdays’, free online art sessions via Zoom.  The sessions are every Wednesday at 2pm and provide an hour for people living with dementia and their companions to get creative and socialise in a friendly and supportive environment.   You can register to attend here: https://artsfordementia.org/events/art-wednesday/  Find out more by emailing…

  • Care Innovation Challenge

    Anyone keen to come up with new ideas for solving problems in the care sector is invited to apply for a Care Innovation Challenge weekend in July.  Cash prizes, expert mentoring and the prospect of media coverage are on offer to the creative thinkers who participate in the weekend, hosted by the Care Innovations Hub,…

  • Research paths

    Alzheimer’s disease research on new treatments is too focused on amyloid build-up in the brain and doesn’t pay adequate attention to other promising research paths, according to a new book.  “Alzheimer’s Disease Research: What has guided research so far and why it is high time for a paradigm shift”, by Professor Christian Behl, was published…

  • FDA approves new Alzheimer’s drug donanemab in the US 

    The US Food and Drug Administration (FDA) has approved donanemab, a drug for Alzheimer’s disease, for people in the US with confirmed amyloid positivity and a diagnosis of mild cognitive impairment (MCI) or early-stage Alzheimer’s disease.  Donanemab is an antibody-based treatment intended to remove amyloid. It is given as an infusion into a person’s arm…